AIDS Healthcare Foundation has recently raised concerns about the impacts of Gilead Sciences' pricing for HIV/AIDS drugs on US state drug assistance programmes for the poor:

“AIDS activists deliver letters to Gilead slamming drug policies”, Silicon Valley / San Jose Business Journal, 19 Aug 2011

 
“Gilead - Drug Prices To Die For”, AIDS Healthcare Foundation, 1 Aug 2011

“AHF: Gilead’s pricing of Complera may break hard-hit AIDS drug programs”, AIDS Healthcare Foundation, 11 Aug 2011

“AHF Hosts Protest & ‘Die-in’ Over Gilead’s AIDS Drug Prices”, AIDS Healthcare Foundation, 3 Aug 2011

Business & Human Rights Resource Centre invited Gilead to respond to these concerns.  Gilead declined to respond, but stated, "We have information on our corporate website, at www.gilead.com, specific to our programs to help ensure patients have access to medications."